WCN'25 CKD-MBD Insights and Innovations for 2025 and Beyond: No Bone Left Uncovered

Hear from the experts about the pathophysiology of CKD-MBD from childhood to the elderly and applying this knowledge in everyday clinical practice. Gain a balanced view of mineral bone disease in CKD, by reviewing a European consensus report and the recent KDIGO controversies conference. Get an update on the challenges and opportunities of existing and emerging bone biomarkers for the evaluation of bone disease in CKD.

Key:

Complete
Failed
Available
Locked
What Should a Clinician Know About CKD-MBD in 2025?
Open to view video.
Open to view video.
CKD-MBD in Children and Young Adults: What's the Difference?
Open to view video.
Open to view video.
Progress in CKD-driven Vascular Calcification: From Bench to Bedside
Open to view video.
Open to view video.
How to Use Serum Biomarkers for Optimal Management of CKD-MBD
Open to view video.
Open to view video.
Q&A
Open to view video.
Open to view video.